Nextar Chempharma Solutions Ltd.

Nextar Chempharma Solutions Ltd. is an Israel-based private biotechnology company focusing on both pharmaceuticals and medical devices, from the initial development stages all the way to the market. Nextar was involved in the development of over 150 innovative products, some for itself and some as a Contract Development and Manufacturing Organization (CDMO). The company's manufacturing capabilities are for small scale sterile and non-sterile products. Nextar is certified for cGMP, GLP, ISO 13485 and ISO 9001, and was successfully audited by the FDA and European notified bodies. Its developed products are globally commercialized. Nextar's proprietary liposonal technology to deliver drugs across the Blood-Brain-Barrier (BBB) : LimoBrain Therapeutics technology, born out of Nextar Chempharma Solutions, is developing a proprietary universal Brain-Targeted Liposomes System (BTLS) platform, which can facilitate targeted delivery of generic and innovative drugs across the blood-brain-barrier (BBB) into the brain.